Research Progress of Chinese Medicine Against Tumor Angiogenesis
DOI:
https://doi.org/10.53469/jcmp.2024.06(11).05Keywords:
Traditional Chinese medicine, Tumor, Anti-angiogenesis, ReviewAbstract
With the continuous development of the society, people's life style and living environment changing, malignant tumor disease from the past rare disease rare disease gradually tends to the high incidence of common disease change, according to incomplete statistics, in 2020, the global 12. 7 million people with new tumors, death 7. 6 million people, with an annual average of 3% to 5% increment, of which 56% of new cases and deaths come from developing countries. In China, the number of new cases of malignant tumors in 2020 will be about 3. 929 million, and the incidence rate of malignant tumors in the country will be 285. 83/100, 000, and the overall situation of prevention and control of malignant tumors is becoming more and more serious. The overall situation of prevention and control of malignant tumors is becoming more and more serious. At the same time, as the occurrence and development process of malignant tumor disease, the key link of tumor angiogenesis, which is decisive, has become an important research direction to inhibit the growth of tumor cells recurrence and metastasis. In recent years, seeking effective anti-tumor angiogenesis components and treatments from traditional Chinese medicine is a hot spot for the treatment of inhibition of the continuous deterioration of malignant tumors. Especially, the effective components of herbal extracts showed strong tumor neovascularization inhibition.
References
FOLKMAN J. Tumor angiogenesis: therapeutic implications [J]. The New England journal of medicine, 1971, 285(21): 1182-1186.
Folkman J,. Anti-angiogenesis: new concept for therapy of solid tumors. [J]. Annals of surgery, 1972, 175(3):409-416.
Dimova Ivanka, Popivanov Georgi, Djonov Valentin, et al. Angiogenesis in cancer - general pathways and their therapeutic implications. [J]. Journal of B. U. ON.: official journal of the Balkan Union of Oncology, 2014, 19(1):15-21.
Ribatti D, Nico B, Crivellato E, et al. The history of the angiogenic switch concept. [J]. Leukemia, 2007, 21(1):44-52.
Dor Y, Porat R, Keshet E, et al. Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis. [J]. American journal of physiology. Cell physiology, 2001, 280(6):C1367-1374.
LITTLEPAGE L E, STERNLICHT M D, ROUGIER N, et al. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression [J]. Cancer research, 2010, 70(6): 2224-2234.
Chrissta X. Maracle, Sander W. Tas,. Inhibitors of angiogenesis: Ready for prime time?[J]. Best Practice & Research Clinical Rheumatology, 2014, 28(4):637-649.
Jakobsson Lars, Franco Claudio A, Bentley Katie, et al. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting [J]. Nature cell biology, 2010, 12(10):943-953.
LIU Z, FAN F, WANG A, et al. Dll4-Notch signaling in regulation of tumor angiogenesis [J]. Journal of cancer research and clinical oncology, 2014, 140(4): 525-536.
H. Izzedine, S. Ederhy, F. Goldwasser, et al. Management of hypertension in angiogenesis inhibitor-treated patients[J]. Annals of Oncology, 2009, 20(5):807-815.
T. Zhang, X. T. Sun. Heart-brain co-ownership of Shenming: The understanding of heart-brain integration [J]. Chinese Rehabilitation Theory and Practice, 2016, 22(003): 368-370.
Cheng HB. Discussion on the theory of cancer toxicity pathogenesis [J]. Journal of Traditional Chinese Medicine, 2014, 55(20): 1711-1714.
Zheng Wei, Yang Xianghong, Wu Lina, et al. Exploration of the molecular mechanism of anti-angiogenesis of curcumin [J]. China Cancer Clinic, 2007, 34(12): 683-685.
Gururaj Anupama E, Belakavadi Madesh, Venkatesh Deepak A, et al. Molecular mechanisms of anti- angiogenic effect of curcumin[J]. Biochemical and biophysical research communications, 2002, 297(4):934-942.
Vuddanda Parameswara Rao, Chakraborty Subhashis, Singh Sanjay, et al. Berberine: a potential phytochemical with multispectrum therapeutic activities. [J]. Expert Opinion on Investigational Drugs, 2010, 19(10):1297-1307.
Luis Miguel Guamán Ortiz, Paolo Lombardi, Micol Tillhon, et al. Berberine, an Epiphany Against Cancer[J]. Molecules, 2014, 19(8):12349-12367.
YUAN Hongxia, ZHANG Lixin, MA Jin, et al. Progress in the study of medicinal components and main pharmacological effects of leeches [J]. Gansu Medical Journal, 2013, 32(4):270-273.
LIU Junshan, ZHANG Dongmei, CHEN Minfeng, et al. Anti-angiogenetic effect of arenobufagin in vitro and in vivo [J]. Acta Pharmaceutica Sinica, 2011, 46(5):527-533.
Manmei Li, Shuai Wu, Zhong Liu, et al. Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway[J]. Biochemical Pharmacology, 2012, 83(9):1251-1260.
Lee D Y, Yasuda M, Yamamoto T, et al. Bufalin inhibits endothelial cell proliferation and angiogenesis in vitro. [J]. Life sciences, 1997, 60(2):127-134.
XI Shengyan, ZHANG Qian, LIU Chaoyang, et al. Effects of safflower fraction HSYA on the expression of VEGF protein, KDR and hypoxia-inducible factor in nude mice transplanted with human gastric adenocarcinoma BGC-823 [J]. Chinese Journal of Traditional Chinese Medicine, 2012, 01): 82-87.
Duan Fengying, Xie Junping, Gao Ting The inhibitory effect of hydroxysaffron yellow pigment A on Lewis lung cancer xenografts in mice [C]//Chinese Medical Association, Respiratory Disease Branch of Chinese Medical Association Chinese Medical Association Respiratory Disease Annual Meeting - Compilation of Papers from the 14th National Respiratory Disease Academic Conference in 2013 Department of Respiratory Medicine, Second Affiliated Hospital of Nanchang University;, 2013:1.
Fangfang Yang, Jingmin Li, Jinhui Zhu, et al. Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice[J]. European Journal of Pharmacology, 2015, 754:105-114.
ZHANG Qian, NIU Xin, YAN Yan, et al. Inhibitory effect of hydroxy saffron yellow pigment A on the proliferation of human umbilical vein endothelial cells cultured in vitro [J]. Chinese Journal of Traditional Chinese Medicine, 2004, 19(006): 379-381.
WANG Ji, ZHANG Qian, XIE Hua, et al. Effect of Hydroxy Safflor Yellow A on the proliferation of human umbilical vein endothelial cells with the stimulus of tumor cell conditioned medium [J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2009, 19(005): 572-575.
Zhang Qian, Niu Xin, Jie Hua, et al. Experimental study on the inhibitory effect of active ingredients in safflower on the angiogenesis of chicken embryo bladder membrane [C]//Chinese Society of Traditional Chinese Medicine, Chinese Journal of Traditional Chinese Medicine Proceedings of the National Symposium on Traditional Chinese Medicine Research and Teaching Reform Molecular Biology Laboratory, School of Basic Medicine, Beijing University of Traditional Chinese Medicine; Molecular Biology Laboratory, School of Basic Medicine, Beijing University of Traditional Chinese Medicine; Molecular Biology Laboratory, School of Basic Medicine, Beijing University of Traditional Chinese Medicine; Molecular Biology Laboratory, School of Basic Medicine, Beijing University of Traditional Chinese Medicine;, 2004:4.
XI Shengyan, ZHANG Qian, LIU Chaoyang, et al. Effects of HSYA on expression of bFGF protein and MMP-9 in BGC-823 transplantation tumor of nude mice [J]. China Journal of Chinese Materia Medica, 2010, 35(21): 2877-2881.
Song Yanmin, Long Lili, Zhang Ning, et al. Inhibitory effects of hydroxysafflor yellow A on PDGF‑BB‑induced proliferation and migration of vascular smooth muscle cells via mediating Akt signaling. [J]. Molecular medicine reports, 2014, 10(3):1555-1560.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Tao Gou, Yucun Zhang
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
